More than 40 hours of presentations—including plenary sessions and award lectures—are available free.
Tumor PD-L2 Expression May Predict Patient Response to Anti-PD-1 Immunotherapy
Stand Up To Cancer Announces Open Call for Ideas for $10 Million Dream Team of Top Investigators
AACR Applauds Presidential Nomination of Norman (“Ned”) Sharpless, MD, as Director of the National Cancer Institute
AACR Publishes First Set of Screening Recommendations Emerging from Childhood Cancer Predisposition Workshop
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept. 6-9, 2017
Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2017
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
This Cancer Research Catalyst blog post highlights the AACR’s recent public education events.
AACR President Michael A. Caligiuri, MD, is quoted in this Science article about President Trump’s pick for NCI Director, Norman (“Ned”) Sharpless, MD.